SIGA Technologies Inc (SIGA)
7.57
+0.21
(+2.85%)
USD |
NASDAQ |
Jun 28, 16:00
7.57
0.00 (0.00%)
After-Hours: 20:00
SIGA Technologies Cash from Investing (Quarterly): 0.00 for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | -0.0217M |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | -0.0262M |
| September 30, 2021 | 0.00 |
| June 30, 2021 | -0.0107M |
| March 31, 2021 | -0.0137M |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | -0.0155M |
| December 31, 2019 | -0.00 |
| September 30, 2019 | -0.0201M |
| June 30, 2019 | 0.00 |
| March 31, 2019 | -0.009M |
| December 31, 2018 | 78.26M |
| September 30, 2018 | 0.00 |
| June 30, 2018 | -0.0279M |
| March 31, 2018 | 0.00 |
| Date | Value |
|---|---|
| December 31, 2017 | -0.0459M |
| September 30, 2017 | -0.0149M |
| June 30, 2017 | -0.0393M |
| March 31, 2017 | |
| December 31, 2016 | 1.200M |
| September 30, 2016 | 0.00 |
| June 30, 2016 | -0.0025M |
| March 31, 2016 | -0.0085M |
| December 31, 2015 | -0.0458M |
| September 30, 2015 | -0.0632M |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 4.00M |
| December 31, 2014 | -0.0022M |
| September 30, 2014 | -3.965M |
| June 30, 2014 | 0.5229M |
| March 31, 2014 | -0.0142M |
| December 31, 2013 | -0.2895M |
| September 30, 2013 | -0.2093M |
| June 30, 2013 | -0.0899M |
| March 31, 2013 | -0.2686M |
| December 31, 2012 | -0.3248M |
| September 30, 2012 | -0.0183M |
| June 30, 2012 | -1.410M |
| March 31, 2012 | -0.1834M |
| December 31, 2011 | -0.1353M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-0.0262M
Minimum
Dec 2021
--
Maximum
Jun 2019
-0.0054M
Average
--
Median
Jun 2020
Cash from Investing (Quarterly) Benchmarks
| Calidi Biotherapeutics Inc | -0.005M |
| Mersana Therapeutics Inc | -72.55M |
| CNS Pharmaceuticals Inc | -- |
| Disc Medicine Inc | -0.067M |
| Amylyx Pharmaceuticals Inc | 0.819M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -6.118M |
| Cash from Financing (Quarterly) | -0.159M |
| Free Cash Flow | 64.23M |
| Free Cash Flow Per Share (Quarterly) | -0.0855 |
| Free Cash Flow to Equity (Quarterly) | -6.118M |
| Free Cash Flow to Firm (Quarterly) | -6.118M |
| Free Cash Flow Yield | 11.86% |